Viridian Therapeutics, Inc. · NASDAQ:VRDN

Point72 Asset Management, L.P. reported a 5.00% stake in Viridian Therapeutics, Inc. (Schedule 13G)

Event Aug 19, 2026 · Filed Aug 20, 2026

Point72 Asset Management, L.P. reported a 5.00% stake in Viridian Therapeutics, Inc., 5,687,507 shares, as a passive investor on Aug 19, 2026. Filed Aug 20, 2026 (Schedule 13G).

Stake
5.00%
Shares
5,687,507
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.00%5,687,507
Point72 Capital Advisors, Inc.5.00%5,687,507
Steven A. Cohen5.00%5,687,507

Source

View original at SEC

Related